Whalesbook
📉 The Financial Deep Dive
The Numbers: Aether Industries Limited announced robust financial results for Q3 FY26, showcasing significant year-on-year growth. Consolidated revenue from operations reached INR 3,171 million, a substantial 44% increase from INR 2,197 million in Q3 FY25. The company's operational efficiency was evident in its EBITDA, which surged by 75% YoY to INR 1,083 million. This strong performance translated into improved profitability, with Profit After Tax (PAT) climbing 49% YoY to INR 645 million.
The Quality: EBITDA margins expanded by 600 basis points to 34% in Q3 FY26, up from 28% in the prior year period. PAT margins also saw an improvement, rising to 20% from 18% YoY. For the nine months of FY26, revenue grew by 43% YoY to INR 8,534 million, while EBITDA increased by 75% YoY to INR 2,716 million, and PAT was up 53% YoY to INR 1,655 million. However, the net working capital cycle saw an increase to 160 days from 149 days, attributed to inventory build-up for upcoming site operations, which management aims to optimize post-commencement.
The Grill: Management expressed confidence in sustaining growth, expecting the share of Oil & Gas and Material Science segments to scale up by fiscal year-end. They reiterated a target for sustainable EBITDA margins around 29-30%, noting that the Q3 FY26 margin of 34% benefited from a one-time claim. The company also highlighted its robust pipeline of innovative customers and exclusive relationships as drivers for filling upcoming capacities.
🚩 Risks & Outlook
Specific Risks: A significant risk flagged is the project related to lithium battery chemicals, which has been put on hold due to aggressive pricing from China. While discussions with customers continue, this represents a potential diversion of resources or delayed revenue stream. The increase in working capital days also warrants close monitoring to ensure efficient cash flow management as new sites ramp up.
The Forward View: Aether Industries is poised for continued growth, driven by the commissioning of Site 3++ and Site 5. The successful addition of three new products to its large-scale manufacturing vertical, targeting pharmaceutical and agrochemical sectors for the first time in India, is a key strategic win. Furthermore, the foray into electronic chemicals for the semiconductor industry with dispatches to key global clients in Japan, South Korea, and Taiwan signals significant diversification and future revenue streams. Management anticipates substantial growth from a new Contract Engineering and Manufacturing (CEM) contract with a European chemical company within a year. Investors should watch for the commencement of commercial production from the new sites and the scaling up of Oil & Gas and Material Science contributions.